{"id":1832,"date":"2001-08-01T12:08:00","date_gmt":"2001-08-01T10:08:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/antibiotische-prophylaxe-einer-borreliose-nach-zeckenbiss-ist-in-der-regel-nicht-sinnvoll"},"modified":"2001-08-01T12:08:00","modified_gmt":"2001-08-01T10:08:00","slug":"antibiotische-prophylaxe-einer-borreliose-nach-zeckenbiss-ist-in-der-regel-nicht-sinnvoll","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/antibiotische-prophylaxe-einer-borreliose-nach-zeckenbiss-ist-in-der-regel-nicht-sinnvoll","title":{"rendered":"Antibiotische Prophylaxe einer Borreliose nach Zeckenbi\u00df ist in der Regel nicht sinnvoll"},"content":{"rendered":"<p>Im Westchester County des Staates New York, USA, ist die Inzidenz der Lyme-Borreliose (Borrelia burgdorferi) mit einem Fall auf 1000 Einwohner\/Jahr sehr hoch. In diesem County f\u00fchrten R.B. Nadelman et al. (N. Engl. J. Med. 2001, 345, 79) eine Prophylaxe-Studie durch. Von 1987 bis 1996 wurden insgesamt 482 Personen, bei denen innerhalb der letzten 72 [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im Westchester County des Staates New York, USA, ist die Inzidenz der Lyme-Borreliose (Borrelia burgdorferi) mit einem Fall auf 1000 Einwohner\/Jahr sehr hoch. In diesem County f\u00fchrten R.B. Nadelman et al. (N. Engl. J. Med. 2001, 345, 79) eine Prophylaxe-Studie durch. Von 1987 bis 1996 wurden insgesamt 482 Personen, bei denen innerhalb der letzten 72 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[22,933,1601,1602,1603,934,932,930,931],"class_list":["post-1832","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-amoxicillin","tag-borreliose","tag-doxycyclin","tag-doxyzyklin","tag-erythema-migrans","tag-lyme-borreliose","tag-zecken","tag-zeckenbiss","tag-zeckenstich"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1832"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1832\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}